YU136490A - Derivati prirolo 2,1-b tiazola - Google Patents
Derivati prirolo 2,1-b tiazolaInfo
- Publication number
- YU136490A YU136490A YU136490A YU136490A YU136490A YU 136490 A YU136490 A YU 136490A YU 136490 A YU136490 A YU 136490A YU 136490 A YU136490 A YU 136490A YU 136490 A YU136490 A YU 136490A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- group
- substituents
- alkyl group
- aryl group
- atom
- Prior art date
Links
- 150000007979 thiazole derivatives Chemical class 0.000 title abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000006165 cyclic alkyl group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
- Pyrrole Compounds (AREA)
Abstract
DERIVATI PRIROLO 2,1-B TIAZOLA. Opisane so nova spojina, ki jo predstavlja tale formula (I) v kateri R1 pomeni atom vodika, alkilno skupino ali ciklično alkilno skupino; R2 pomeni hidroksilno skupino, alkoksi skupino, ki ima lahko 1 do 3 substituente v delu alkilne skupine, ariltio, skupino, ki ima lahko 1 ali več substituentov v delu arilne skupine, ariloksi skupino, ki ima lahko 1 ali več substituentov v delu arilne skupine, amino skupino, alkilamino skupino ali ciklično amino skupino, ki lahko vsebuje 1 ali več heteroatomov kot obročne atome, izbrane izmed atoma dušika, atoma kisika in atoma žvepla; R3 pomeni atom vodika, alkilno skupino, arilno skupino, ki ima lahko 1 ali več substituentov, ali hetero arilno skupino, ki ima lahko 1 ali več substituentov; in -------- pomeni enojno vez ali dvojno vez; njene soli in farmacevtski pripravki za preprečevanje in zdravljenje bolezni jeter, ki vsebujejo spojine s formulo (I) ali njene soli kot učinkovino.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15114189 | 1989-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU136490A true YU136490A (sh) | 1992-09-07 |
Family
ID=15512262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU136490A YU136490A (sh) | 1989-06-13 | 1990-07-12 | Derivati prirolo 2,1-b tiazola |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5098919A (sh) |
| EP (1) | EP0410224B1 (sh) |
| JP (1) | JP2875605B2 (sh) |
| KR (1) | KR910002874A (sh) |
| CN (1) | CN1025337C (sh) |
| AT (1) | ATE132870T1 (sh) |
| AU (1) | AU624724B2 (sh) |
| CA (1) | CA2021135A1 (sh) |
| DD (1) | DD296492A5 (sh) |
| DE (1) | DE69024713T2 (sh) |
| DK (1) | DK0410224T3 (sh) |
| ES (1) | ES2084622T3 (sh) |
| FI (1) | FI903511A0 (sh) |
| GR (1) | GR3018798T3 (sh) |
| HU (1) | HU207331B (sh) |
| IE (1) | IE902545A1 (sh) |
| IL (1) | IL95021A (sh) |
| NO (1) | NO903084L (sh) |
| NZ (1) | NZ234450A (sh) |
| PT (1) | PT94688A (sh) |
| RU (2) | RU1836374C (sh) |
| YU (1) | YU136490A (sh) |
| ZA (1) | ZA905407B (sh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050244892A1 (en) * | 2004-02-27 | 2005-11-03 | Lazar Mitchell A | Resistin as a marker and therapeutic target for cardiovascular disease |
| ES2431578T3 (es) * | 2008-04-09 | 2013-11-27 | B.R.A.H.M.S Gmbh | Proendotelina-1 para la predicción del consumo de oxígeno máximo disminuido |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193926A (en) * | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
| US4347186A (en) * | 1980-10-20 | 1982-08-31 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein |
-
1990
- 1990-07-10 IL IL9502190A patent/IL95021A/en not_active IP Right Cessation
- 1990-07-10 ZA ZA905407A patent/ZA905407B/xx unknown
- 1990-07-10 DD DD90342652A patent/DD296492A5/de not_active IP Right Cessation
- 1990-07-11 NO NO90903084A patent/NO903084L/no unknown
- 1990-07-11 NZ NZ234450A patent/NZ234450A/xx unknown
- 1990-07-11 AU AU58904/90A patent/AU624724B2/en not_active Ceased
- 1990-07-11 FI FI903511A patent/FI903511A0/fi not_active Application Discontinuation
- 1990-07-11 KR KR1019900010442A patent/KR910002874A/ko not_active Application Discontinuation
- 1990-07-12 YU YU136490A patent/YU136490A/sh unknown
- 1990-07-12 ES ES90113378T patent/ES2084622T3/es not_active Expired - Lifetime
- 1990-07-12 EP EP90113378A patent/EP0410224B1/en not_active Expired - Lifetime
- 1990-07-12 DE DE69024713T patent/DE69024713T2/de not_active Expired - Fee Related
- 1990-07-12 PT PT94688A patent/PT94688A/pt not_active Application Discontinuation
- 1990-07-12 IE IE254590A patent/IE902545A1/en unknown
- 1990-07-12 DK DK90113378.5T patent/DK0410224T3/da active
- 1990-07-12 AT AT90113378T patent/ATE132870T1/de not_active IP Right Cessation
- 1990-07-12 RU SU904830592A patent/RU1836374C/ru active
- 1990-07-13 JP JP2186896A patent/JP2875605B2/ja not_active Expired - Fee Related
- 1990-07-13 CA CA002021135A patent/CA2021135A1/en not_active Abandoned
- 1990-07-13 CN CN90107066A patent/CN1025337C/zh not_active Expired - Fee Related
- 1990-07-13 US US07/552,031 patent/US5098919A/en not_active Expired - Fee Related
- 1990-07-13 HU HU904214A patent/HU207331B/hu not_active IP Right Cessation
-
1991
- 1991-08-22 RU SU915001347A patent/RU2026288C1/ru active
-
1996
- 1996-01-25 GR GR960400186T patent/GR3018798T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1049350A (zh) | 1991-02-20 |
| HU207331B (en) | 1993-03-29 |
| IL95021A0 (en) | 1991-06-10 |
| DD296492A5 (de) | 1991-12-05 |
| NZ234450A (en) | 1991-10-25 |
| RU1836374C (ru) | 1993-08-23 |
| HUT57221A (en) | 1991-11-28 |
| DK0410224T3 (da) | 1996-02-05 |
| AU5890490A (en) | 1991-01-17 |
| RU2026288C1 (ru) | 1995-01-09 |
| NO903084D0 (no) | 1990-07-11 |
| GR3018798T3 (en) | 1996-04-30 |
| AU624724B2 (en) | 1992-06-18 |
| ATE132870T1 (de) | 1996-01-15 |
| KR910002874A (ko) | 1991-02-26 |
| HU904214D0 (en) | 1990-12-28 |
| US5098919A (en) | 1992-03-24 |
| EP0410224B1 (en) | 1996-01-10 |
| IL95021A (en) | 1994-06-24 |
| ES2084622T3 (es) | 1996-05-16 |
| EP0410224A1 (en) | 1991-01-30 |
| DE69024713D1 (de) | 1996-02-22 |
| JPH03128385A (ja) | 1991-05-31 |
| ZA905407B (en) | 1991-04-24 |
| CA2021135A1 (en) | 1991-01-14 |
| CN1025337C (zh) | 1994-07-06 |
| IE902545A1 (en) | 1991-02-27 |
| PT94688A (pt) | 1991-03-20 |
| DE69024713T2 (de) | 1996-06-13 |
| NO903084L (no) | 1991-01-14 |
| FI903511A0 (fi) | 1990-07-11 |
| JP2875605B2 (ja) | 1999-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI882081A0 (fi) | 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning. | |
| DE3674232D1 (de) | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel. | |
| LV5269A3 (lv) | Pristinamicina p beta atvasinajumu iegusanas panemiens izomeru vai to maisijuma veida vai skabju-aditivo saju veida | |
| FR2669927B1 (fr) | Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| FI874865A (fi) | Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi | |
| YU136490A (sh) | Derivati prirolo 2,1-b tiazola | |
| DK0541407T3 (da) | Nitrogenholdige, bicykliske derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem | |
| NO159269C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske fenylamidiner. | |
| DK350084A (da) | 2-substituerede 4-phenylimidazolderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
| IT8621999A1 (it) | Derivati pirido-benzotiazinici ad attività antibatterica ed a lunga durata di azione |